Screening and identification of the H1R antagonists from natural products by BODIPY FL histamine recognition and DPHD-anchored bombardment coupled with target cell extraction

IntroductionHistamine is an important mediator of allergy, and inhibiting its binding to H1 receptors (H1R) is a key method to alleviate allergic diseases. Natural products with anti-allergic properties are an important source of natural H1R antagonists.MethodsIn this study, a rapid method for ident...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinqi Li, Guizhou Hu, Xu Chen, Can Di, Jin Qi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1601384/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850238332258222080
author Xinqi Li
Guizhou Hu
Guizhou Hu
Xu Chen
Can Di
Jin Qi
author_facet Xinqi Li
Guizhou Hu
Guizhou Hu
Xu Chen
Can Di
Jin Qi
author_sort Xinqi Li
collection DOAJ
description IntroductionHistamine is an important mediator of allergy, and inhibiting its binding to H1 receptors (H1R) is a key method to alleviate allergic diseases. Natural products with anti-allergic properties are an important source of natural H1R antagonists.MethodsIn this study, a rapid method for identifying the H1R antagonists from natural products via the BODIPY FL histamine recognition and diphenhydramine (DPHD)-anchored bombardment coupled with target cell extraction was developed. In addition, the activity of the H1R antagonist was further validated both in vitro and in vivo through BODIPY FL histamine recognition, intracellular fluorescence calcium ion (Ca2+) kinetic recognition, molecular docking, and animal experiments.ResultsThe binding of fluorescent histamine to H1R was notably inhibited by Ephedra sinica Stapf (ESS) and Dictamnus dasycarpus Turcz (DdT). Ephedrine and pseudoephedrine in ESS and dictamnine and limonin in DdT were screened as potential H1R antagonists using the target cell extraction of the DPHD-anchored bombardment. The BODIPY FL histamine recognition results revealed the significant blocking effects on H1R binding by pseudoephedrine (50 μM) and dictamnine (100 μM). Pseudoephedrine (200 μM) and dictamnine (100 μM) markedly decreased the histamine-induced increase in intracellular calcium ion (Ca2+) concentration. Docking results indicated strong binding affinity for both components to H1R, with dictamnine exhibiting a higher affinity than pseudoephedrine. Ultimately, the ameliorative effect of dictamnine on allergic rhinitis mice was confirmed through nasal symptom score, serum pharmacodynamic indices (immunoglobulin E (IgE), histamine, IL-2, IL-4, IL-6, and TNF-α), and histopathology.ConclusionThis study showed that dictamnine (validated in vitro and in vivo) and pseudoephedrine (validated in vitro) may serve as potential H1R antagonists. This study offered valuable insights for future developments in antihistamines.
format Article
id doaj-art-9c28ae0135cb48bc9035b127869dfea3
institution OA Journals
issn 1663-9812
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-9c28ae0135cb48bc9035b127869dfea32025-08-20T02:01:29ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-05-011610.3389/fphar.2025.16013841601384Screening and identification of the H1R antagonists from natural products by BODIPY FL histamine recognition and DPHD-anchored bombardment coupled with target cell extractionXinqi Li0Guizhou Hu1Guizhou Hu2Xu Chen3Can Di4Jin Qi5Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, ChinaResearch Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, ChinaState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, ChinaBYHEALTH Institute of Nutrition and Health, Guangzhou, ChinaBYHEALTH Institute of Nutrition and Health, Guangzhou, ChinaResearch Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, ChinaIntroductionHistamine is an important mediator of allergy, and inhibiting its binding to H1 receptors (H1R) is a key method to alleviate allergic diseases. Natural products with anti-allergic properties are an important source of natural H1R antagonists.MethodsIn this study, a rapid method for identifying the H1R antagonists from natural products via the BODIPY FL histamine recognition and diphenhydramine (DPHD)-anchored bombardment coupled with target cell extraction was developed. In addition, the activity of the H1R antagonist was further validated both in vitro and in vivo through BODIPY FL histamine recognition, intracellular fluorescence calcium ion (Ca2+) kinetic recognition, molecular docking, and animal experiments.ResultsThe binding of fluorescent histamine to H1R was notably inhibited by Ephedra sinica Stapf (ESS) and Dictamnus dasycarpus Turcz (DdT). Ephedrine and pseudoephedrine in ESS and dictamnine and limonin in DdT were screened as potential H1R antagonists using the target cell extraction of the DPHD-anchored bombardment. The BODIPY FL histamine recognition results revealed the significant blocking effects on H1R binding by pseudoephedrine (50 μM) and dictamnine (100 μM). Pseudoephedrine (200 μM) and dictamnine (100 μM) markedly decreased the histamine-induced increase in intracellular calcium ion (Ca2+) concentration. Docking results indicated strong binding affinity for both components to H1R, with dictamnine exhibiting a higher affinity than pseudoephedrine. Ultimately, the ameliorative effect of dictamnine on allergic rhinitis mice was confirmed through nasal symptom score, serum pharmacodynamic indices (immunoglobulin E (IgE), histamine, IL-2, IL-4, IL-6, and TNF-α), and histopathology.ConclusionThis study showed that dictamnine (validated in vitro and in vivo) and pseudoephedrine (validated in vitro) may serve as potential H1R antagonists. This study offered valuable insights for future developments in antihistamines.https://www.frontiersin.org/articles/10.3389/fphar.2025.1601384/fullBODIPY FL histamineH1R antagoniststarget cell extractionHPLC-Q-TOF-MSnatural productsdictamnine
spellingShingle Xinqi Li
Guizhou Hu
Guizhou Hu
Xu Chen
Can Di
Jin Qi
Screening and identification of the H1R antagonists from natural products by BODIPY FL histamine recognition and DPHD-anchored bombardment coupled with target cell extraction
Frontiers in Pharmacology
BODIPY FL histamine
H1R antagonists
target cell extraction
HPLC-Q-TOF-MS
natural products
dictamnine
title Screening and identification of the H1R antagonists from natural products by BODIPY FL histamine recognition and DPHD-anchored bombardment coupled with target cell extraction
title_full Screening and identification of the H1R antagonists from natural products by BODIPY FL histamine recognition and DPHD-anchored bombardment coupled with target cell extraction
title_fullStr Screening and identification of the H1R antagonists from natural products by BODIPY FL histamine recognition and DPHD-anchored bombardment coupled with target cell extraction
title_full_unstemmed Screening and identification of the H1R antagonists from natural products by BODIPY FL histamine recognition and DPHD-anchored bombardment coupled with target cell extraction
title_short Screening and identification of the H1R antagonists from natural products by BODIPY FL histamine recognition and DPHD-anchored bombardment coupled with target cell extraction
title_sort screening and identification of the h1r antagonists from natural products by bodipy fl histamine recognition and dphd anchored bombardment coupled with target cell extraction
topic BODIPY FL histamine
H1R antagonists
target cell extraction
HPLC-Q-TOF-MS
natural products
dictamnine
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1601384/full
work_keys_str_mv AT xinqili screeningandidentificationoftheh1rantagonistsfromnaturalproductsbybodipyflhistaminerecognitionanddphdanchoredbombardmentcoupledwithtargetcellextraction
AT guizhouhu screeningandidentificationoftheh1rantagonistsfromnaturalproductsbybodipyflhistaminerecognitionanddphdanchoredbombardmentcoupledwithtargetcellextraction
AT guizhouhu screeningandidentificationoftheh1rantagonistsfromnaturalproductsbybodipyflhistaminerecognitionanddphdanchoredbombardmentcoupledwithtargetcellextraction
AT xuchen screeningandidentificationoftheh1rantagonistsfromnaturalproductsbybodipyflhistaminerecognitionanddphdanchoredbombardmentcoupledwithtargetcellextraction
AT candi screeningandidentificationoftheh1rantagonistsfromnaturalproductsbybodipyflhistaminerecognitionanddphdanchoredbombardmentcoupledwithtargetcellextraction
AT jinqi screeningandidentificationoftheh1rantagonistsfromnaturalproductsbybodipyflhistaminerecognitionanddphdanchoredbombardmentcoupledwithtargetcellextraction